Amarin Corporation PLC (NASDAQ:AMRN)
| 6.25 BATS BZX Real-Time Price As of 2:01pm ET |  +0.17 / +2.80%Today’s Change | 3.36 Today|||52-Week Range 21.82 | +27.81% Year-to-Date |
Latest AMRN News | Press Releases
| Wall Street Was Busy Selling These 2 Stocks in 2020 Jan 16 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.08 |
| Today’s open | 5.92 |
| Day’s range | 6.15 - 6.57 |
| Volume | 404,650 |
| Average volume (3 months) | 7,586,191 |
| Market cap | $2.4B |
Data as of 2:01pm ET, 01/19/2021
Growth & Valuation
| Earnings growth (last year) | +83.02% |
| Earnings growth (this year) | +19.67% |
| Earnings growth (next 5 years) | +36.10% |
| Revenue growth (last year) | +88.59% |
| P/E ratio | NM |
| Price/Sales | 17.02 |
| Price/Book | 3.73 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Oxford BioMedica PLC | +0.01 | +0.10% |
| FGENFibroGen Inc | +0.84 | +1.94% |
| DBVTDBV Technologies SA | +0.88 | +15.58% |
| BCELAtreca Inc | +0.54 | +3.56% |
Data as of 2:00pm ET, 01/19/2021
Financials
| Next reporting date | March 2, 2021 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $431.5M |
| Annual profit (last year) | -$22.7M |
| Net profit margin | -5.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
